VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27 | -85.8% | 2,495 | -86.7% | 0.00% | -88.9% |
| Q2 2023 | $190 | -24.0% | 18,706 | -57.1% | 0.03% | +8.0% |
| Q1 2023 | $250 | +71.2% | 43,595 | -29.0% | 0.02% | +108.3% |
| Q4 2022 | $146 | -99.3% | 61,400 | +340.6% | 0.01% | +500.0% |
| Q3 2022 | $22,000 | -8.3% | 13,934 | -3.5% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -38.5% | 14,434 | -21.3% | 0.00% | 0.0% |
| Q1 2022 | $39,000 | -72.9% | 18,334 | -53.3% | 0.00% | -75.0% |
| Q1 2020 | $144,000 | +260.0% | 39,300 | +327.2% | 0.01% | +300.0% |
| Q4 2019 | $40,000 | -27.3% | 9,200 | -8.0% | 0.00% | -60.0% |
| Q3 2019 | $55,000 | -16.7% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $66,000 | -18.5% | 10,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $81,000 | -19.0% | 10,000 | -39.4% | 0.01% | -20.0% |
| Q4 2018 | $100,000 | -78.0% | 16,500 | -66.9% | 0.01% | -68.8% |
| Q3 2018 | $454,000 | +135.2% | 49,830 | -26.6% | 0.03% | +113.3% |
| Q2 2018 | $193,000 | – | 67,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |